Overall, these observations support the notion that CLL is associated with a substantial decline in the frequency of CD26+ T cells, particularly CD26lowCD8+ T cells, without any changes in the plasma levels of soluble CD26. This evidence concerns the gene DPP4 and B-cell chronic lymphocytic leukemia.